Trial Profile
Phase IIb trial of AVA-101 in patients with wet age related macular degeneration
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 16 Mar 2015
Price :
$35
*
At a glance
- Drugs AVA 101 (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 16 Mar 2015 New trial record